2017
(P2017-01) High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients
S. Castelain, V. Descamps, E. Brochot, F. Helle, G. Duverlie, E. Nguyen-Khac, C. François
Arch. Virol. 2017, 162(7), 1913-1920; doi: 10.1007/s00705-017-3312-6.
(P2017-02) DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase
L. Handala, B. Domange, H. Ouled-Haddou, L. Garçon, E. Nguyen Khac, F. Helle, S. Bodeau, G. Duverlie, E. Brochot
Antiviral Res. 2017, 146, 153-160; doi: 10.1016/j.antiviral.2017.09.002.
(P2017-03) Biology of the BKPyV: An update
F. Helle, E. Brochot, L. Handala, E. Martin, S. Castelain, C. François, G. Duverlie
Viruses 2017, 9(11), 327; doi: 10.3390/v9110327.
(P2017-04) Targeting the unfolded protein response as a potential therapeutic strategy in renal carcinoma cells exposed to cyclosporine A
S. Bodeau, C. Sauzay, R. Nyga, C. Louandre, V. Descamps, C. François, C. Godin, G. Choukroun, A. Galmiche
Anticancer Res. 2017, 37(3), 1049-1057; doi: 10.21873/anticanres.11416.
(P2017-05) A simple and reliable strategy for BK virus subtyping and subgrouping
V. Morel, E. Martin, C. François, F. Helle, J. Faucher, T. Mourez, G. Choukroun, G. Duverlie, S. Castelain, E. Brochot
J. Clin. Microbiol. 2017, 55(4), 1177-1185; doi: 10.1128/JCM.01180-16.
(P2017-06) Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles
C. Oliveira, C. Fournier, V. Descamps, V. Morel, C. A. Scipione, R. Romagnuolo, M. L. Koschinsky, A. Boullier, P. Marcelo, J. M. Domon, E. Brochot, G. Duverlie, C. François, S. Castelain, F. Helle
Hepatology 2017, 65(6), 1851-1864; doi: 10.1002/hep.29096.
(P2017-07) Evaluation of the phytoremediation potential of Arundo Donax L. for Nickel contaminated soil
W. Atma, M. Larouci, B. Meddah, K. Benabdeli, P. Sonnet
Int. J. Phytoremediation 2017, 19(4), 377-386; doi: 10.1080/15226514.2016.1225291.
(P2017-08) Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives
J. Guillon, A. Cohen, N. M. Gueddouda, R. Nath Das, S. Moreau, L. Ronga, S. Savrimoutou, L. Basmacyian, A. Monnier, M. Monget, S. Rubio, T. Garnerin, N. Azas, J.-L. Mergn, C. Mullié, P. Sonnet
J. Enzyme Inhib. Med. Chem. 2017, 32, 547-563; doi: 10.1080/14756366.2016.1268608.
(P2017-09) Anti-mycotoxin effect and antifungal properties of essential oil from Ammodaucus leucotrichus Coss. & Dur. on Aspergillus flavus and Aspergillus ochraceus
A. Khaldi, B. Meddah, A. Moussaoui, P. Sonnet
J. Essent. Oil Bear. Pl. 2017, 20(1), 36-44; doi: 10.1080/0972060X.2017.1282840.
(P2017-10) Synthesis and antiproliferative effect of new ethyl 4-(4-substitutedpiperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate derivatives on human leukemic cells
V. Desplat, M. Vincenzi, R. Lucas, S. Moreau, S. Savrimoutou, S. Rubio, N. Pinaud, D. Bigat, E. Enriquez, M. Marchivie, S. Routier, P. Sonnet, F. Rossi, L. Ronga, J. Guillon
ChemMedChem 2017, 12, 940-953; doi: 10.1002/cmdc.201700049.
(P2017-11) Enantiopure amino-alcohol fluorenes as new antimalarial drugs
J. Schneider, A. Dassonville-Klimpt, N. Taudon, P. Sonnet
Pharmaceuticals 2017, 10(1), 17, 15-16; doi: 10.3390/ph10010017.
(P2017-12) Oligogalacturonic acid inhibits vascular calcification through interaction with collagen
A. Hodroge, E. Trecherel, M. Cornu, K. Ait-Mohand, T. Verissimo, C. Gomila, C. Cathy, C. Schrembi, S. Da Nascimento, E. Elboutachfait, A. Boullier, E. Lorne, J. Courtois, E. Petit, S. Toumieux, J. Kovensky, P. Sonnet, Z. Massy, S. Kamel, C, Rossi, J. Ausseil
Arterioscler. Thromb. Vasc. Biol. 2017, 37 (7), 1391-1401; doi: 10.1161/ATVBAHA.117.309513.
(P2017-13) Synthesis, iron(III) complexation properties, molecular dynamics simulations and P. aeruginosa siderophore-like activity of two pyoverdine analogs
V. Antonietti, S. Boudesocque, L. Dupont, N. Farvacques, C. Cézard, S. Da Nascimento, J.-F. Raimbert, L. Socrier, T. J. Robin, S. Morandat, K. El Kirat, C. Mullié, P. Sonnet
Eur. J. Med. Chem. 2017, 137, 338-350; doi: 10.1016/j.ejmech.2017.06.010.
(P2017-14) Essential Oil from the leaves of Ajuga iva: chemical composition and antimicrobial activity
O. Chouitah, B. Meddah, P. Sonnet
J. Essent. Oil Bear. Pl. 2017, 20(3), 873-877; doi: 10.1080/0972060X.2017.1337526.
(P2017-15) Phytochemical study of Zygophyllum album extract
A. Belmimoun, B. Meddah, S. Larbi, P. Sonnet
Int. J. Eng. Technol. Manag. Res. 2017, 4 (5), 1-10; doi: 10.5281/zenodo.805965.
(P2017-16) PCR detection of staphylococcal enterotoxin genes and exfoliative toxin genes in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains from raw human breast milk
A. Leke, S. Goudjil, C. Mullié, S. Grognet, M. Biendo
Clin. Nutr. Exp. 2017, 14, 26-35 ; doi.org/10.1016/j.yclnex.2017.05.001.
(P2017-17) Role of TLRs and IL-6 in the outcome of chronic hepatitis C treatment in Tunisian population.
I. Sghaier, L. Mouelhi, E. Ghazoueni, E. Brochot, W. Y. Almawi, B. Yacoubi-Loueslati
Cytokine 2017, 99, 297-304; doi: 10.1016/j.cyto.2017.08.010.
(P2017-18) Hemoglobin during ribavirin-based HCV therapy is closely related to circulating levels of DHEA
S. Bodeau, J.-P. Lemouel, M. Diouf, G. Duverlie, E. Nguyen-Khac, E. Brochot
J. Med. Virol. 2017, 89(6), 1033-1039; doi: 10.1002/jmv.24726.
(P2017-19) Identification of novel functions for Hepatitis C virus envelope glycoprotein E1 in virus entry and assembly
J. G. Haddad, Y. Rouillé, X. Hanoulle, V. Descamps, M. Hamze, F. Dabboussi, T. F. Baumert, G. Duverlie, M. Lavie, J. Dubuisson
J. Virol. 2017, 91(16), e00438-17; doi: 10.1128/JVI.00048-17.
(P2017-20) Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France
S. Leroy, J. Benzaquen, A. Mazzetta, S. Marchand-Adam, B. Padovani, D. Israel-Biet, C. Pison, P. Chanez, J. Cadranel, J. Mazières, V. Jounieaux, C. Cohen, V. Hofman, M. Ilie, P. Hofman, C.-H. Marquette, AIR Project Study Group
BMJ Open. 2017, 7(12), e018884; doi: 10.1136/bmjopen-2017-018884.
(P2017-21) Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study
G. Deslée, S. Leroy, J.-M. Perotin, H. Mal, H. Dutau, A. Bourdin, J.-M. Vergnon, C. Pison, R. Kessler, V. Jounieaux, M. Salaün, A. Marceau, S. Dury, J. Benzaquen, M. Bonnaire, S. Dukic, C. Barbe, C.-H. Marquette, REVOLENS Study Group
Eur. Respir. J. 2017, 50(6), 1701740; doi: 10.1183/13993003.01740-2017.
(P2017-22) Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia: A cohort study
D. Basille, N. Plouvier, C. Trouve, P. Duhaut, C. Andrejak, V. Jounieaux
Lung 2017, 195(2), 201-208; doi: 10.1007/s00408-016-9973-1.
(P2017-23) Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients
R.-A. Lavergne, T. Chouaki, F. Hagen, B. Toublanc, H. Dupont, V. Jounieaux, J. F. Meis, F. Morio, P. Le Pape
Clin. Infect. Dis. 2017, 64(1), 76-78; doi.org/10.1093/cid/ciw664.
(P2017-24) Evaluation of the phytoremediation potential of Arundo Donax L. for Nickel contaminated soil
W. Atma, M. Larouci, B. Meddah, K. Benabdeli, P. Sonnet
Int. J. Phytoremediation 2017, 19(4), 377-386; doi.org/10.1080/15226514.2016.1225291.
(P2017-25) A case of acute clival osteomyelitis in a 7-year-old boy secondary to infection of a Thornwaldt cyst
Y. Benadjaoud, N. Klopp-Dutote, M. Choquet, E. Brunel, R. Guihéneuf, C. Page
Int. J. Pediatr. Otorhinolaryngol. 2017, 95, 87-90; doi.org/10.1016/j.ijporl.2017.02.008.
(P2017-26) Seasonal flu vaccination: a matter of choice?
J.-P. Lanoix, C. Douadi, Y. El Samad, J.-L. Schmit
J. Hosp. Infect. 2017, 96(3), 302-303; doi: 10.1016/j.jhin.2017.04.016.
(P2017-27) In Vivo-selected pyrazinoic acid-resistant Mycobacterium tuberculosisstrains harbor missense mutations in the aspartate decarboxylase PanD and the unfoldase ClpC1
P. Gopal, R. Tasneen, M. Yee, J.-P. Lanoix, J. Sarathy, G. Rasic, L. Li, V. Dartois, E. Nuermberger, T. Dick
ACS Infect. Dis. 2017, 3(7), 492-501; doi: 10.1021/acsinfecdis.7b00017.
2016
(P2016-01) Asymmetric synthesis of new antimalarial aminoquinolines through Sharpless aminohydroxylation
G. Bentzinger, W. De Souza, C. Mullié, P. Agnamey, A. Dassonville-Klimpt, P. Sonnet
Tetrahedron: Asymmetry 2016, 27, 1-11; doi.org/10.1016/j.tetasy.2015.11.003.
(P2016-02) The origin of the stereoselective alkylation of 3-substituted-2-oxopiperazines: a computational investigation
C. Cézard, B. Bouvier, A. Dassonville-klimpt, P. Sonnet
Comput. Theor. Chem. 2016, 1078, 1-8; doi.org/10.1016/j.comptc.2015.12.005.
(P2016-03) β-hematin crystal formation: New insights from molecular dynamics simulations of small clusters in condensed phase
J.-P. Becker, F. Wang, P. Sonnet, F.-Y. Dupradeau
Cryst. Growth Des. 2016, 16, 2249-2259; doi: 10.1021/acs.cgd.6b00052.
(P2016-04) Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines
V. Desplat, M. Vincenzi, R. Lucas, S. Moreau, S. Savrimoutou, N. Pinaud, J. Lesbordes, E. Peyrilles, M. Marchivie, S. Routier, P. Sonnet, F. Rossi, L. Ronga, J. Guillon
Eur. J. Med. Chem. 2016, 113, 214-227; doi.org/10.1016/j.ejmech.2016.02.047.
(P2016-05) Effects of 3G cell phone exposure on the structure and function of the human cytochrome P450 reductase
S. Tanvir, G. Thuroczy, B. Selmaoui, V. Silva Pires-Antonietti, P. Sonnet, D. Arnaud-Cormos, P. Lévêque, S. Pulvin, R. de Seze.
BioElectoChemistry 2016, 11, 62-69; doi: 10.1016/j.bioelechem.2016.05.005.
(P2016-06) Conversion of dermal proteins of an algerian ovine to an antimicrobial agent for skin lesion
M. D. Tabak, B. Meddah, P. Sonnet
J. Environ. Sci. Eng. B 2016, 5, 11-16; doi:10.17265/2162-5263/2016.01.002.
(P2016-07) The antibacterial effect of two medicinal plants inula viscosa, anacyclus valentinus (Asteraceae) and their synergistic interaction with antibiotic drugs
K. Side Larbi, B. Meddah, A. T. T. Meddah, P. Sonnet
J. Fundam. Appl. Sci. 2016, 8(2), 244-255; doi: 10.4314/jfas.v8i2.5.
(P2016-08) Antibacterial and antioxidant activities of the essential oils and phenolic extracts of myrtus communis and zygophylum album from Algeria
A. Belmimoun, B. Meddah, A. T. T. Meddah, P. Sonnet
J. Fundam. Appl. Sci. 2016, 8(2), 510-524; doi: 10.4314/jfas.v8i2.22.
(P2016-09) Design, synthesis and antimalarial activity of some new aminoalcohol-pyrrolo[1,2-a]quinoxaline derivatives
J. Guillon, S. Moreau, L. Ronga, L. Basmacyian, A. Cohen, S. Rubio, G. Bentzinger, S. Hutter, N. Azas, C. Mullié, P. Sonnet
Lett. Drug Des. Discov. 2016, 13(9), 932-942; doi: 10.2174/1570180813666160517164758.
(P2016-10) Multifunctional diamine AGE/ALE inhibitors with potential therapeutical properties againts Alzheimer’s disease
E. Lohou, N. A. Sasaki, A. Boullier, P. Sonnet
Eur. J. Med. Chem. 2016, 122, 702-722; doi: 10.1016/j.ejmech.2016.04.069.
(P2016-11) Hepatitis C virus resistance to carbohydrate-binding agents
L. Izquierdo, C. Oliveira, C. Fournier, V. Descamps, V. Morel, J. Dubuisson, E. Brochot, C. François, S. Castelain, G. Duverlie, F. Helle
PLoS One 2016, 11(2), e0149064; doi: 10.1371/journal.pone.0149064.
(P2016-12) Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
A. Houessinon, C. François, C. Sauzay, C. Louandre, G. Mongelard, C. Godin, S. Bodeau, S. Takahashi, Z. Saidak, L. Gutierrez, J.-M. Régimbeau, N. Barget, J.-C. Barbare, N. Ganne, B. Chauffert, R. Coriat, A. Galmiche
Mol. Cancer 2016, 15(1), 38; doi 10.1186/s12943-016-0526-2.
(P2016-13) Different precore/core mutations of hepatitis B interact with, limit or favor liver fibrosis severity
A. Ducancelle, A. Pivert, S. Bertrais, J. Boursier, V. Balan, P. Veillon, H. le Guillou-Guillemette, V. Thibault, S. Castelain, B. Roquebert, M. Coste-Burel, V. Mackiewicz, E. Schvoerer, S. Larrat, S. Maylin, S. Alain, V. Loustaud-Ratti, E. Gordien, J. Gozlan, V. Brodard, S. Chevaliez, P. Calès, F. Lunel-Fabiani
J. Gastroenterol. Hepatol. 2016, 31(10), 1750-1756; doi: 10.1111/jgh.13338.
(P2016-14) Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia
V. Decroix, E. Pluquet, M. Choquet, N. Menouche, S. Castelain, R. Guihéneuf
Anaerobe 2016, 39, 28-30; doi: 10.1016/j.anaerobe.2016.02.005.
(P2016-15) Antiviral activities of different interferon types and subtypes against hepatitis E virus replication
D. Todt, C. François, Anggakusuma, P. Ehrendt, M. Engelmann, L. Knegendorf, G. Vieyres, H. Wedemeyer, R. Hartmann, T. Pietschmann, G. Duverlie, E. Steinmann
Antimicrob. Agents Chemother. 2016, 60(4), 2132-2139; doi: 10.1128/AAC.02427-15.
(P2016-16) Management of colorectal cancer in patients with cirrhosis: A retrospective, case-matched study of short- and long-term outcomes
C. Sabbagh, D. Chatelain, E. Nguyen-Khac, L. Rebibo, J.-P. Joly, J.-M. Regimbeau
Dig. Liver Dis. 2016, 48(4), 429-434; doi: 10.1016/j.dld.2015.12.004.
(P2016-17) Modeling of HBV and HCV hepatitis with hepatocyte-like cells
A. Bengrine, E. Brochot, M. Louchet, Y. E. Herpe, G. Duverlie
Front Biosci. (Schol Ed) 2016, 8, 97-105; doi: 10.2741/s449.
(P2016-18) Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to orafenib
A. Houessinon, A. Gicquel, F. Bochereau, C. Louandre, R. Nyga, C. Godin, J. Degonville, E. Fournier, Z. Saidak, C. Drullion, J.-C. Barbare, B. Chauffert, C. François, O. Pluquet, A. Galmiche
Cancer Lett. 2016, 370(2), 242-249; doi: 10.1016/j.canlet.2015.10.032.
(P2016-19) Chemical composition and properties of essential oil of Rosmarinus officinalis and Populus Alba
H. Belkhodja, B. Meddah, A. Tir Touil, N. Şekeroğlu, P. Sonnet
WJPPS 2016, 5(9), 108-119; doi: 10.20959/wjpps20169-7558.
(P2016-20) N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: an update on an old uremic toxin
A. Lenglet, S. Liabeuf, S. Bodeau, L. Louvet, A. Mary, A. Boullier, A. S. Lemaire-Hurtel, A. Jonet, P. Sonnet, S. Kamel, Z. A. Massy
Toxins 2016, 8(11), 339; doi:10.3390/toxins8110339.
(P2016-21) The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation
E. Brochot, J. Desoutter, C. Presne, I. De Araujo, G. Flahaut, S. Castelain, P. F. Westeel, G. Choukroun, N. Guillaume
Transpl. Int. 2016, 29(11), 1168-1175; doi: 10.1111/tri.12820.
(P2016-22) Bartholinitis due to Aggregatibacter aphrophilus: a case report
M. Choquet, E. Pluquet, S. Castelain, R. Guihéneuf, V. Decroix
BMC Infect. Dis. 2016, 16(1), 574; doi: 10.1186/s12879-016-1908-1.
(P2016-23) Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.
V. Morel, F. Ghoubra, L. Izquierdo, E. Martin, C. Oliveira, C. François, E. Brochot, F. Helle, G. Duverlie, S. Castelain
Infect. Genet. Evol. 2016, 40, 374-380; doi: 10.1016/j.meegid.2015.09.030.
(P2016-24) Performance qualification of two processor-controlled dosing pumps for the production of mixed infusion solutions in a closed system
T. Hennache, G. Clabaut, L. Mustapha, J.-M. Dubaele, F. Marçon
Pharm. Technol. Hosp. Pharm. 2016, 1(1), 29-35; doi: 10.1515/pthp-2015-0008.
(P2016-25) Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial
G. Deslée, H. Mal, H. Dutau, A. Bourdin, J.-M. Vergnon, C. Pison, R. Kessler, V. Jounieaux, L. Thiberville, S. Leroy, A. Marceau, S. Laroumagne, J.-P. Mallet, S. Dukic, C. Barbe, J. Bulsei, D. Jolly, I. Durand-Zaleski, C.-H. Marquette; for the REVOLENS Study Group
JAMA 2016, 315(2), 175-184; doi:10.1001/jama.2015.17821.
(P2016-26) Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodeling at Interferon Stimulated Genes
B. Testoni, D. Durantel, F. Lebossé, J. Fresquet, F. Helle, F. Negro, M. F. Donato, M. Levrero, F. Zoulim
Gut 2016, 65, 672-682; doi.org/10.1136/gutjnl-2014-309011.
(P2016-27) Morbimortality in adult patients with septic arthritis: a three-year hospital-based study
J. Ferrand, Y. El Samad, B. Brunschweiler, F. Grados, N. Dehamchia-Rehailia, A. Séjourne, J.-L. Schmit, A. Gabrion, P. Fardellone, J. Paccou
BMC Infect Dis. 2016, 16, 239; doi 10.1186/s12879-016-1540-0.
(P2016-28) Hepatitis C: the path towards effective universal therapy
L. Piroth, C. Rabaud, D. Rey, J.-L. Schmit, C. Chirouze, G. Beck-Wirth, O. Robineau, F. Bani-Sadr; ICONE Study Group
The Lancet 2016, 388(10049), 1051-1052; doi.org/10.1016/S0140-6736(16)31540-9.
(P2016-29) Tolerability and plasma drug level monitoring of prolonged subcutaneous teicoplanin treatment for bone and joint infections
Y. El Samad, J.-P. Lanoix, Y. Bennis, M. Diouf, C. Saroufim, B. Brunschweiler, F. Rousseau, C. Joseph, F. Hamdad, M. Ait Amer Meziane, S. Routier, J.-L. Schmit
Antimicrob. Agents Chemother. 2016, 60(10), 6365-6368; doi 10.1128/AAC.00351-16.
(P2016-30) High systemic exposure of pyrazinoic acid has limited antituberculosis activity in murine and rabbit models of tuberculosis
J.-P. Lanoix, R. Tasneen, P. O'Brien, J. Sarathy, H. Safi, M. Pinn, D. Alland, V. Dartois, E. Nuermberger
Antimicrob. Agents Chemother. 2016, 60(7),4197-4205; doi 10.1128/AAC.03085-15.
(P2016-31) Shortening tuberculosis treatment with fluoroquinolones: lost in translation?
J.-P. Lanoix, R. E. Chaisson, E. L. Nuermberger
Clin. Infect. Dis. 2016, 62(4),484-490; doi: 10.1093/cid/civ911.